Funding round
Baseimmune Seed
Baseimmune, which works in active immunotherapy development in London, raised $945K in a Seed round announced on 1 Apr 2021, led by The Creator Fund. 5 firms took part. It is Baseimmune's first venture round on record.
$945K
Amount raised
685,000 GBP converted
Not disclosed
Post-money valuation
5
Investors
1 lead
Valuation
What this round says about the price
Baseimmune did not disclose a valuation in this round. It is Baseimmune's first venture round on record, 2 years after it was founded in 2019. It is 7.7% of the $12M Baseimmune has raised in the venture rounds on record. Baseimmune raised again 34 months later: a Series A round of $11M in Feb 2024.
Baseimmune's funding rounds
Baseimmune has 2 venture rounds on record and 1 other deal. This one is highlighted.
- Seed this round 1 Apr 2021, led by The Creator Fund $945K
- Other not a venture round 2 Nov 2021, led by Hoxton Ventures $4.8M
- Series A 26 Feb 2024, led by MSD Global Health Innovation Fund and IQ Capital $11M
Investors
Who put money in
The Creator Fund led the round with 4 other firms.
Lead investor
- backs 19 venture-backed companies new investor
Also in the round
- backs 32 venture-backed companies new investor
- backs 3 venture-backed companies new investor
- Vaccitech new investor
- Oxford University new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
117 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $5.0M, and this round was 19% of the median. The closest in time, other companies' Seed rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 30 Apr 2021 | $17M | not disclosed | not named |
| Biotechnology | 20 Apr 2021 | $10M | not disclosed | 4BIO Capital and UPMC Enterprises |
| Biotechnology | 21 Apr 2021 | $10M | not disclosed | Smooth River and Hong Kong Hongrun |
| Biotechnology | 5 Apr 2021 | $1.8M | not disclosed | not named |
| Biotechnology | 20 May 2021 | $20M | not disclosed | Broadview Ventures |
| Biotechnology | 25 May 2021 | $18M | not disclosed | Vivo Capital |
| Biotechnology | 10 May 2021 | $17M | not disclosed | SV Health Investors and MRL Ventures Fund |
| Colossal Biotechnology | 1 May 2021 | $15M | not disclosed | Thomas Tull |
Sources
Where this comes from
Reported by 1 source. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Baseimmune raise in its Seed round?
Baseimmune raised $945K in its Seed round, announced in Apr 2021.
Who led Baseimmune's Seed round?
The Creator Fund led it, with Maki.vc, Rockmount Capital, Vaccitech and Oxford University.
What was Baseimmune's valuation at the Seed round?
It was not disclosed.
How does it compare with other Seed rounds in Biotechnology?
117 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $5.0M, and this round was 19% of the median.
Did Baseimmune raise again after this round?
Yes: a Series A round in Feb 2024 of $11M.